Chemoinformaics analysis of (Z)-14-Methylhexadec-8-enal
| Molecular Weight | 252.442 | nRot | 13 |
| Heavy Atom Molecular Weight | 220.186 | nRig | 1 |
| Exact Molecular Weight | 252.245 | nRing | 0 |
| Solubility: LogS | -4.297 | nHRing | 0 |
| Solubility: LogP | 5.09 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 50.5294 |
| nHD | 0 | BPOL | 32.9706 |
| QED | 0.414 |
| Synth | 2.086 |
| Natural Product Likeliness | 1.571 |
| NR-PPAR-gamma | 0.057 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.138 |
| HIA | 0.004 |
| CACO-2 | -4.397 |
| MDCK | 0.0000211 |
| BBB | 0.582 |
| PPB | 0.96666 |
| VDSS | 2.096 |
| FU | 0.0282134 |
| CYP1A2-inh | 0.922 |
| CYP1A2-sub | 0.197 |
| CYP2c19-inh | 0.376 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.343 |
| CYP2c9-sub | 0.934 |
| CYP2d6-inh | 0.02 |
| CYP2d6-sub | 0.147 |
| CYP3a4-inh | 0.15 |
| CYP3a4-sub | 0.067 |
| CL | 7.307 |
| T12 | 0.46 |
| hERG | 0.074 |
| Ames | 0.01 |
| ROA | 0.028 |
| SkinSen | 0.96 |
| Carcinogencity | 0.111 |
| EI | 0.971 |
| Respiratory | 0.335 |
| NR-Aromatase | 0.119 |
| Antiviral | Yes |
| Prediction | 0.741435 |